DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal ...
The group sees Schedule III as "inadequate" for veterans' needs. But the DEA excluded it from the witness list, and a judge ...
As the federal government considers loosening restrictions on marijuana, the Drug Enforcement Administration is scheduled to ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling hearing, deferring to DEA Administrator Anne Milgram's authority. MedPharm, a ...
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.
Schedule III drugs, as defined by the DEA, are "drugs with a moderate to low potential for physical and psychological ...
DEA and anti-cannabis group must respond to allegations of unlawful talks by November 25. Legal tensions rise ahead of ...